Par Drugs and Chemicals Limited
Fixed Price IPO · NSE
- Price band
- ₹51 - ₹51
- Lot size
- 2,000 shares
- Issue amount
- ₹9 cr
- Total subscription
- 0×
- Opens
- 3 May 2019
- Closes
- 8 May 2019
- Allotment
- 13 May 2019
- Listing
- 16 May 2019
Offer at a glance
Issue overview
- Issue size
- 16,72,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,02,000
- Fresh issue
- ₹0 cr
- Offer for sale
- ₹0 cr
- Registrar
- Link Intime India Private Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,02,000
- Issue type
- Fixed Price IPO
- Shares before issue
- 44,80,318
- Shares after issue
- 61,52,318
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 1 | ₹1,02,000 |
| HNI | 2 | 2 | ₹2,04,000 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
in Lakhs · Reported periods may include interim results.
Company information
Company profile
Par Drugs and Chemicals Limited, incorporated in 1999 and based in Gujarat, is engaged in the manufacturing and development of active pharmaceutical ingredients (APIs) and fine chemicals for both domestic and international markets. Its APIs are used in tablets, capsules, and other finished dosages, and it also produces various antacid molecules. The company operates two manufacturing facilities in Ankleshwar and Bhavnagar, Gujarat, and offers a portfolio of 6 fine chemicals and 12 API products sold across 17 countries. Key customers include Dabur India Ltd, Meyer Organics Pvt. Ltd, Cadila Healthcare Ltd., Cipla Ltd, and Pfizer Ltd. For fiscal 2018, international sales accounted for 86.88% of total revenue, while domestic sales contributed 13.12%. The company maintains a testing laboratory to ensure quality standards and provides drying operations to convert liquid products into powders for its clients.
Strengths
- Diversified Product Range: Offers a wide variety of products.
- International Presence: Operates in global markets.
- Efficient Distribution: Prompt and reliable sales and distribution network.
- Proven Track Record: Established history of strong performance.
- Strong Chemistry Capabilities: Expertise in chemical processes and development.
Promoters
Mr. Falgun Vallabhbhai Savani
Mr. Jignesh Vallabhbhai Savani
Registrar & documents
Lead manager
Pantomath Capital Advisor Private Limited
Registrar & contacts
Link Intime India Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
805, Dwarkesh Complex, R.C. Dutt Road, Alkapuri, Vadodara-390 007,
+91 265 2332018
[email protected]Company website ↗Understanding PAR IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.